WOLFGANG WINKELMAYER to Proton Pump Inhibitors
This is a "connection" page, showing publications WOLFGANG WINKELMAYER has written about Proton Pump Inhibitors.
Connection Strength
1.006
-
Proton Pump Inhibitors, Histamine-2 Receptor Antagonists, and Hip Fracture Risk among Patients on Hemodialysis. Clin J Am Soc Nephrol. 2018 10 08; 13(10):1534-1541.
Score: 0.514
-
Proton Pump Inhibitor Use and Risk of Hip Fracture in Kidney Transplant Recipients. Am J Kidney Dis. 2017 May; 69(5):595-601.
Score: 0.452
-
Proton pump inhibitors may enhance the risk of citalopram- and escitalopram-associated sudden cardiac death among patients receiving hemodialysis. Pharmacoepidemiol Drug Saf. 2022 06; 31(6):670-679.
Score: 0.041